We are live on ! Find out more
VRM

Vectors Research Management Portfolio holdings

AUM $383M
1-Year Est. Return 30.23%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
AUM
$354M
AUM Growth
-$911K
Cap. Flow
-$285M
Cap. Flow %
-80.51%
Top 10 Hldgs %
41.9%
Holding
144
New
4
Increased
35
Reduced
77
Closed
12

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$96.5M
2
MSFT icon
Microsoft
MSFT
+$55.3M
3
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$40.4M
4
PG icon
Procter & Gamble
PG
+$35.4M
5
IBM icon
IBM
IBM
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 9.49%
2 Healthcare 6.71%
3 Industrials 5.49%
4 Energy 4.65%
5 Financials 3.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROP icon
76
Roper Technologies
ROP
$38.8B
$1.08M 0.31%
1,934
-111
-5% -$60.6K
TGT icon
77
Target
TGT
$67.8B
$1.08M 0.3%
6,080
CAT icon
78
Caterpillar
CAT
$404B
$1.05M 0.3%
2,867
-184
-6% -$58.8K
SYK icon
79
Stryker
SYK
$131B
$1.01M 0.28%
2,817
+527
+23% +$177K
REGN icon
80
Regeneron Pharmaceuticals
REGN
$78.2B
$987K 0.28%
1,025
-39
-4% -$37.1K
USB icon
81
US Bancorp
USB
$99.6B
$956K 0.27%
21,385
-1,612
-7% -$68K
ADM icon
82
Archer Daniels Midland
ADM
$38.5B
$950K 0.27%
15,125
-673
-4% -$39.5K
BAC icon
83
Bank of America
BAC
$440B
$948K 0.27%
25,000
DVN icon
84
Devon Energy
DVN
$50.8B
$927K 0.26%
18,478
-1,486
-7% -$66K
TRV icon
85
Travelers Companies
TRV
$78.7B
$921K 0.26%
4,000
-225
-5% -$48.1K
JNJ icon
86
Johnson & Johnson
JNJ
$613B
$896K 0.25%
5,664
-211
-4% -$33.6K
KR icon
87
Kroger
KR
$35.4B
$893K 0.25%
15,637
-1,044
-6% -$51.4K
ROST icon
88
Ross Stores
ROST
$80.5B
$881K 0.25%
6,000
BSX icon
89
Boston Scientific
BSX
$71.1B
$860K 0.24%
12,563
+1,685
+15% +$108K
VRP icon
90
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$804K 0.23%
33,819
-1,448
-4% -$34K
CAG icon
91
Conagra Brands
CAG
$7.14B
$803K 0.23%
27,104
-1,512
-5% -$43.2K
SPY icon
92
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$764K 0.22%
1,461
-286
-16% -$142K
BMY icon
93
Bristol-Myers Squibb
BMY
$135B
$718K 0.2%
13,247
-183
-1% -$9.32K
FMC icon
94
FMC
FMC
$1.3B
$699K 0.2%
10,972
-1,803
-14% -$105K
GILD icon
95
Gilead Sciences
GILD
$168B
$673K 0.19%
9,189
-269
-3% -$20.7K
MCD icon
96
McDonald's
MCD
$191B
$639K 0.18%
2,268
-46
-2% -$13.4K
ALTM
97
DELISTED
Arcadium Lithium plc
ALTM
$579K 0.16%
+134,450
New +$674K
PSX icon
98
Phillips 66
PSX
$82.7B
$578K 0.16%
3,536
+3
+0.1% +$432
CF icon
99
CF Industries
CF
$18.1B
$573K 0.16%
6,880
-505
-7% -$40.3K
CTVA icon
100
Corteva
CTVA
$50.7B
$527K 0.15%
9,131
-561
-6% -$29K

Similar funds

Vectors Research Management's Q1 2024 Portfolio in Review

As of Q1 2024, Vectors Research Management held 144 positions worth $354M, down 0.26% from $355M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Vectors Research Management withdrew a net $285M in Q1 2024, closing 12 positions and reducing 77 holdings. Its most notable exit was Accenture, an estimated $2.37M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.5% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vectors Research Management opened a new position in Arcadium Lithium plc worth $579K.

  • Vectors Research Management's largest Q1 2024 buy was Arcadium Lithium plc: 134,450 shares worth $579K.
  • Vectors Research Management added most to Invesco Variable Rate Investment Grade ETF in Q1 2024, an estimated $10.2M increase.
  • Vectors Research Management's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $96.5M.
  • Vectors Research Management fully exited Accenture in Q1 2024, selling an estimated $2.37M.
  • Vectors Research Management's ten largest holdings make up 42% of its $354M portfolio in Q1 2024.
  • Vectors Research Management opened 4 new positions and closed 12 in Q1 2024.
  • Vectors Research Management's portfolio value fell 0.26% quarter-over-quarter to $354M.

Based on Vectors Research Management's 13F filing for Q1 2024, filed 15 May 2024.